CNS Pharmaceuticals (CNSP) Reports Q4 Loss of $0.17/sh

CNS Pharmaceuticals (NASDAQ: CNSP) reported Q4 EPS of ($0.17), versus ($0.63) reported last year.

For earnings history and earnings-related data on CNS Pharmaceuticals (CNSP) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'